|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 387.10 INR | -1.36% |
|
-4.00% | +24.71% |
| 05-27 | SMS Pharmaceuticals Limited, Q4 2026 Earnings Call, May 27, 2026 | |
| 05-22 | SMS Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 | CI |
| Market Cap | 35.11B 364M 318M 295M 270M 511M 520M 3.51B 1.38B 17.14B 1.37B 1.34B 59.19B | P/E 2024 |
30.3x | P/E 2025 | 27.3x |
|---|---|---|---|---|---|
| Enterprise Value | 37.8B 392M 343M 317M 291M 551M 560M 3.78B 1.49B 18.46B 1.47B 1.44B 63.73B | EV / Sales 2024 |
2.47x | EV / Sales 2025 | 2.75x |
| Free-Float |
23.47% | Yield 2024 |
0.22% | Yield 2025 | 0.19% |
Last Transcript: SMS Pharmaceuticals Limited
| 1 day | -1.36% | ||
| 1 week | -4.00% | ||
| Current month | -6.17% | ||
| 1 month | +2.41% | ||
| 3 months | -11.68% | ||
| 6 months | +14.78% | ||
| Current year | +24.71% |
| 1 week | 384.05 |  | 411.3 |
| 1 month | 370.35 | | 438.3 |
| Current year | 293.15 | | 447.8 |
| 1 year | 207.99 | | 447.8 |
| 3 years | 100.8 | | 447.8 |
| 5 years | 54.55 | | 447.8 |
| 10 years | 24 | | 447.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 66 | 30/08/1990 | |
| Director of Finance/CFO | - | 13/09/2017 | |
| Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 66 | 30/08/1990 | |
| Director/Board Member | 37 | 05/06/2020 | |
| Director/Board Member | 48 | 29/05/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.36% | -4.00% | +58.39% | +281.00% | 382M | |
| -0.07% | +3.28% | +12.89% | +81.75% | 48.66B | |
| +0.59% | -1.21% | +67.38% | +116.30% | 35.52B | |
| -0.59% | -0.16% | -4.12% | +38.67% | 12.07B | |
| -0.26% | +0.51% | +19.25% | +93.82% | 11.99B | |
| +1.13% | +1.15% | +32.83% | +126.50% | 9.29B | |
| -1.76% | -5.73% | +41.23% | -7.49% | 6.92B | |
| +0.50% | +0.58% | +19.74% | +38.26% | 7B | |
| -0.46% | +2.84% | +2.73% | +225.72% | 6.74B | |
| +7.04% | +14.92% | -10.65% | +29.12% | 6.36B | |
| Average | +0.45% | +1.12% | +23.97% | +102.36% | 14.49B | |
| Weighted average by Cap. | +0.34% | +1.27% | +26.93% | +89.04% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 7.09B 73.61M 64.34M 59.5M 54.6M 103M 105M 710M 279M 3.46B 276M 270M 11.96B | 7.83B 81.23M 71.01M 65.67M 60.26M 114M 116M 783M 308M 3.82B 305M 298M 13.2B |
| Net income | 498M 5.17M 4.52M 4.18M 3.84M 7.26M 7.39M 49.85M 19.58M 243M 19.42M 18.99M 840M | 691M 7.17M 6.27M 5.8M 5.32M 10.07M 10.25M 69.17M 27.17M 338M 26.94M 26.35M 1.17B |
| Net Debt | 2.45B 25.39M 22.19M 20.52M 18.83M 35.65M 36.26M 245M 96.15M 1.19B 95.35M 93.25M 4.12B | 2.69B 27.94M 24.43M 22.59M 20.73M 39.23M 39.91M 269M 106M 1.31B 105M 103M 4.54B |
Employees
1,470
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/07/26 | ₹387.10 | -1.36% | 139,223 |
| 15/07/26 | ₹392.45 | -1.70% | 128,764 |
| 14/07/26 | ₹399.25 | -0.14% | 411,138 |
| 13/07/26 | ₹399.80 | -0.72% | 564,457 |
| 10/07/26 | ₹402.70 | -1.07% | 389,683 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SMSPHARMA Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
